Navigation Links
Diabetes Management Provider ActiveCare Announces Cost Savings Of Over $4,000 Per Year Per Diabetic Member
Date:11/15/2012

SALT LAKE CITY, Nov. 15, 2012 /PRNewswire/ -- ActiveCare, Inc. (OTC.BB: ACAR), the service leader in disease and diabetes management solutions, announced a dramatic decrease in diabetic claims in the first twelve months of its relationship with Caprock HealthPlans. ActiveCare's revolutionary health monitoring and information technology combined with a dedicated staff of care specialists has lead to a healthier Caprock. By collecting real-time biometric readings ActiveCare is able to interpret the readings and communicate with the plan members, caregivers, physicians, diabetes management and wellness coordinators within minutes of a blood glucose test. "ActiveCare has made an immediate impact on the programs we are able to offer our plan members. Monitoring and care services have enabled us to better meet the needs of our members and lower the cost of care," stated David M. Adams, president of Caprock. "This savings is a great platform for us to continue to grow our relationship with ActiveCare by allowing us to expand this service to all of our current customers."

As a result of the rapid adoption of its revolutionary Diabetes Management System during the past six months ActiveCare has grown from 661 to more than 6,000 program members. "Many organizations aspire to 'deliver better care at a lower cost.' We actually do it," notes Michael Jones, Chief Operating Officer of ActiveCare. "By combining real-time monitoring of blood glucose levels with analysis of individuals' previous care, we are able to guide plan members as they proactively treat their disease. The result is better care and a reduction of diabetes-related claims by $4,000 per year." The Company is projecting to add an additional 8,000 new members by the end of the year.

About ActiveCare
ActiveCare, Inc. is the telehealth and personal emergency response solution leader. Headquartered in Salt Lake City, Utah, and publicly traded on the OTC Bulletin Board under symbol ACAR, ActiveCare is committed to providing consistent excellence in quality and safety, and friendly care for members and caregivers alike. To learn more about ActiveCare, Inc., visit the website at www.activecare.com or contact investor/media relations at 877-862-5545 or ir@activecare.com.

About Caprock HealthPlans, Inc.
Caprock HealthPlans, Inc. is a Lubbock, Texas, based Third Party Administrator formed in June of 2000 and operates with a Certificate of Authority issued by the Texas Department of Insurance. We provide turnkey health plan administration services to businesses and governmental entities electing to self-insure their employer sponsored healthcare benefit plan.

Safe Harbor
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE ActiveCare, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Purple corn compound may aid in developing future treatments for Type 2 diabetes, kidney disease
2. Risk of developing diabetes higher in neighborhoods that arent walk-friendly: Study
3. Cystic fibrosis disrupts pancreas two ways in CF-related diabetes
4. Shedding new light on one of diabetes most dangerous complications
5. A mechanism providing clues for research into pancreatic diabetes is described
6. Specific toxic byproduct of heat-processed food may lead to increased body weight and diabetes
7. Drink made from berry wine may provide tasty drug for diabetes
8. Organic study of live pancreatic tissue yields new opportunities for diabetes research
9. 10 new diabetes gene links offer picture of biology underlying disease
10. Hormone in fruit flies sheds light on diabetes cure, weight-loss drug for humans
11. BUSM study identifies receptors role in regulating obesity, type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology: